Cargando…
Rapid target validation in a Cas9-inducible hiPSC derived kidney model
Recent advances in induced pluripotent stem cells (iPSCs), genome editing technologies and 3D organoid model systems highlight opportunities to develop new in vitro human disease models to serve drug discovery programs. An ideal disease model would accurately recapitulate the relevant disease phenot...
Autores principales: | Shamshirgaran, Yasaman, Jonebring, Anna, Svensson, Anna, Leefa, Isabelle, Bohlooly-Y, Mohammad, Firth, Mike, Woollard, Kevin J., Hofherr, Alexis, Rogers, Ian M., Hicks, Ryan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368200/ https://www.ncbi.nlm.nih.gov/pubmed/34400685 http://dx.doi.org/10.1038/s41598-021-95986-5 |
Ejemplares similares
-
Editing the genome of hiPSC with CRISPR/Cas9: disease models
por: Bassett, Andrew R.
Publicado: (2017) -
hiPSC-Derived Cells as Models for Drug Discovery
por: Ofir, Rivka
Publicado: (2021) -
A mathematical model of hiPSC cardiomyocytes electromechanics
por: Forouzandehmehr, Mohamadamin, et al.
Publicado: (2021) -
Characterizing the secretome of licensed hiPSC-derived MSCs
por: Ramos, Yolande F. M., et al.
Publicado: (2022) -
Generation of hiPSC-Derived Skeletal Muscle Cells: Exploiting the Potential of Skeletal Muscle-Derived hiPSCs
por: Metzler, Eric, et al.
Publicado: (2022)